1,881
Views
1
CrossRef citations to date
0
Altmetric
Review

Early considerations of genetics in aphasia rehabilitation: a narrative review

, &
Pages 835-853 | Received 17 Feb 2021, Accepted 14 Feb 2022, Published online: 25 Feb 2022

References

  • Arne, L., & Jane, M. (2016). Stroke recovery genetics. Stroke, 47(9), 2427–2434. https://doi.org/10.1161/STROKEAHA.116.010648
  • Ashley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., Dudley, J. T., Ormond, K. E., Pavlovic, A., Morgan, A. A., Pushkarev, D., Neff, N. F., Hudgins, L., Gong, L., Hodges, L. M., Berlin, D. S., Thorn, C. F., Sangkuhl, K., Hebert, J. M., … Altman, R. B. (2010). Clinical assessment incorporating a personal genome. The Lancet, 375(9725), 1525–1535. https://doi.org/10.1016/S0140-6736(10)60452-7
  • Atkinson, E. G., Audesse, A. J., Palacios, J. A., Bobo, D. M., Webb, A. E., Ramachandran, S., & Henn, B. M. (2018). No evidence for recent selection at FOXP2 among diverse human populations. Cell, 174(6), 1424–1435.e15. https://doi.org/10.1016/j.cell.2018.06.048
  • Bartlett, C. W., Flax, J. F., Logue, M. W., Smith, B. J., Vieland, V. J., Tallal, P., & Brzustowicz, L. M. (2004). Examination of potential overlap in autism and language loci on chromosomes 2, 7, and 13 in two independent samples ascertained for specific language impairment. Human Heredity, 57(1), 10–20. https://doi.org/10.1159/000077385
  • Bartlett, C. W., Flax, J. F., Logue, M. W., Vieland, V. J., Bassett, A. S., Tallal, P., & Brzustowicz, L. M. (2002). A major susceptibility locus for specific language impairment is located on 13q21. The American Journal of Human Genetics, 71(1), 45–55. https://doi.org/10.1086/341095
  • Bartlett, C. W., Hou, L., Flax, J. F., Hare, A., Cheong, S. Y., Fermano, Z., Zimmerman-Bier, B., Cartwright, C., Azaro, M. A., Buyske, S., & Brzustowicz, L. M. (2014). A genome scan for loci shared by autism spectrum disorder and language impairment. American Journal of Psychiatry, 171(1), 72–81. https://doi.org/10.1176/appi.ajp.2013.12081103
  • Bath, K. G., & Lee, F. S. (2006). Variant BDNF (Val66Met) impact on brain structure and function. Cognitive, Affective, and Behavioral Neuroscience, 6(1), 79–85. https://doi.org/10.3758/CABN.6.1.79
  • Benjamin, J., Patterson, C., Greenberg, B. D., Murphy, D. L., Hamer, D. H., & Hamer, D. H. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. (1996). Nature Genetics, 12(1), 81–84. PubMed: 8528258. https://doi.org/10.1038/ng0196-81
  • Biffi, A., Anderson, C. D., Jagiella, J. M., Schmidt, H., Kissela, B., Hansen, B. M., Jimenez-Conde, J., Pires, C. R., Ayres, A. M., Schwab, K., Cortellini, L., Pera, J., Urbanik, A., Romero, J. M., Rost, N. S., Goldstein, J. N., Viswanathan, A., Pichler, A., Enzinger, C., … Rosand, J. (2011). APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: A genetic association study. The Lancet Neurology, 10(8), 702–709. https://doi.org/10.1016/S1474-4422(11)70148-X
  • Bliss, T. V. P., & Collingridge, G. L. (1993). A synaptic model of memory: Long-term potentiation in the hippocampus. Nature, 361(6407), 31–39. https://doi.org/10.1038/361031a0
  • Blomert, L., Kean, M. L., Koster, C., & Schokker, J. (1994). Amsterdam—Nijmegen everyday language test: Construction, reliability and validity. Aphasiology, 8(4), 381–407. https://doi.org/10.1080/02687039408248666
  • Burggren, A. C., Zeineh, M. M., Ekstrom, A. D., Braskie, M. N., Thompson, P. M., Small, G. W., & Bookheimer, S. Y. (2008). Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E ε4 carriers. NeuroImage, 41(4), 1177–1183. https://doi.org/10.1016/j.neuroimage.2008.03.039
  • Cambon, K., Davies, H. A., & Stewart, M. G. (2000). Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human Apolipoprotein E4 transgenic mice. Neuroscience, 97(4), 685–692. https://doi.org/10.1016/S0306-4522(00)00065-8
  • Caselli, R. J., Graff-Radford, N. R., Reiman, E. M., Weaver, A., Osborne, D., Lucas, J., Uecker, A., & Thibodeau, S. N. (1999). Preclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes. Neurology, 53(1). https://doi.org/10.1212/WNL.53.1.201
  • Cedazo-Minguez, A. (2007). Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. Journal of Cellular and Molecular Medicine, 11(6), 1227–1238. doi:10.1111/j.1582-4934.2007.00130.x
  • Chen, C.-L., Tang, F.-T., Chen, H.-C., Chung, C.-Y., & Wong, M.-K. (2000). Brain lesion size and location: Effects on motor recovery and functional outcome in stroke patients. Archives of Physical Medicine and Rehabilitation, 81(4), 447–452. https://doi.org/10.1053/mr.2000.3837
  • Chervyakov, A. V., Chernyavsky, A. Y., Sinitsyn, D. O., & Piradov, M. A 2015. Possible mechanisms underlying the therapeutic effects of transcranial magnetic stimulation. Frontiers in Human Neuroscience, 9, 1–14. https://doi.org/10.3389/fnhum.2015.00303:
  • Chytrova, G., Ying, Z., & Gomez‐Pinilla, F. (2008). Exercise normalizes levels of MAG and Nogo-A growth inhibitors after brain trauma. European Journal of Neuroscience, 27(1), 1–11. https://doi.org/10.1111/j.1460-9568.2007.05982.x
  • Cohen, R. M., Small, C., Lalonde, F., Friz, J., & Sunderland, T. (2001). Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology, 57(12), 2223–2228. https://doi.org/10.1212/WNL.57.12.2223
  • Collins, F. S. (2001). Implications of the human genome project for medical science. The Journal of the American Medical Association, 285(5), 540–544. https://doi.org/10.1001/jama.285.5.540
  • Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261(5123), 921–923. https://doi.org/10.1126/science.834644
  • Cramer, S. C., & Procaccio, V. (2012). Correlation between genetic polymorphisms and stroke recovery: Analysis of the GAIN Americas and GAIN international studies. European Journal of Neurology, 19(5), 718–724. https://doi.org/10.1111/j.1468-1331.2011.03615.x
  • Curtis, C. L., Goldberg, A., Kleim, J. A., & Wolf, S. L. (2016). Translating genomic advances to physical therapist practice: A closer look at the nature and nurture of common diseases. Physical Therapy, 96(4), 570–580. https://doi.org/10.2522/ptj.20150112
  • De Blasi, S., Montesanto, A., Martino, C., Dato, S., De Rango, F., Bruni, A. C., Mari, V., Feraco, E., & Passarino, G. (2009). APOE polymorphism affects episodic memory among non demented elderly subjects. Experimental Gerontology, 44(3), 224–227. https://doi.org/10.1016/j.exger.2008.11.005
  • De Boer, R. G. A., Spielmann, K., Heijenbrok-Kal, M. H., van der Vliet, R., Ribbers, G. M., & van de Sandt-koenderman, W. M. E. (2017). The role of the BDNF Val66Met polymorphism in recovery of aphasia after stroke. Neurorehabilitation and Neural Repair, 31(9), 851–857. https://doi.org/10.1177/1545968317723752
  • Di Lazzaro, V., Pellegrino, G., Di Pino, G., Corbetto, M., Ranieri, F., Brunelli, N., Paolucci, M., Bucossi, S., Ventriglia, M. C., Brown, P., & Capone, F. (2015). Val66Met BDNF gene polymorphism influences human motor cortex plasticity in acute stroke. Brain Stimulation, 8(1), 92–96. https://doi.org/10.1016/j.brs.2014.08.006
  • Di Pino, G., Pellegrino, G., Capone, F., Assenza, G., Florio, L., Falato, E., Lotti, F., & Di Lazzaro, V. (2016). Val66Met BDNF polymorphism implies a different way to recover from stroke rather than a worse overall recoverability. Neurorehabilitation and Neural Repair, 30(1), 3–8. https://doi.org/10.1177/1545968315583721
  • Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., & Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112(2), 257–269. https://doi.org/10.1016/S0092-8674(03)00035-7
  • Enard, W., Przeworski, M., Fisher, S. E., Lai, C. S. L., Wiebe, V., Kitano, T., Monaco, A. P., & Pääbo, S. (2002). Molecular evolution of FOXP2, a gene involved in speech and language. Nature, 418(6900), 869–872. https://doi.org/10.1038/nature01025
  • Fisher, S. E., Vargha-Khadem, F., Watkins, K. E., Monaco, A. P., & Pembrey, M. E. (1998). Localisation of a gene implicated in a severe speech and language disorder. Nature Genetics, 18(2), 168–170. https://doi.org/10.1038/ng0298-168
  • Fossella, J., Sommer, T., Fan, J., Wu, Y., Swanson, J. M., Pfaff, D. W., & Posner, M. I. (2002). Assessing the molecular genetics of attention networks. BMC Neuroscience, 3(1), 14. PubMed: 12366871 https://doi.org/10.1186/1471-2202-3-14
  • Fridriksson, J., Elm, J., Stark, B. C., Basilakos, A., Rorden, C., Sen, S., George, M. S., Gottfried, M., & Bonilha, L. (2018). BDNF genotype and tDCS interaction in aphasia treatment. Brain Stimulation, 11(6), 1276–1281. https://doi.org/10.1016/j.brs.2018.08.009
  • Frizzell, J. P. (2005). Acute stroke: Pathophysiology, diagnosis, and treatment. AACN Clinical Issues, 16(4), 421–440. https://doi.org/10.1097/00044067-200510000-00002
  • Frosch, M., Anthony, D., & De Girolami, U. (2005). The central nervous system. In V. Kumar, A. Abbas, & N. Fausto (Eds.), Robbins & cotran pathologic basis of disease (7th ed., pp. 1347–1419). Elsevier Saunders.
  • Ganesh Santhi, K., Arnett Donna, K., Assimes Themistocles, L., Basson Craig, T., Aravinda, C., Ellinor Patrick, T., Engler Mary, B., Elizabeth, G., Herrington David, M., Hershberger Ray, E., Yuling, H., Johnson Julie, A., Kittner Steven, J., McDermott Deborah, A., Meschia James, F., Mestroni Luisa, O. C., Psaty Bruce, J., Vasan Ramachandran, M., Waldman Scott A, S., … Waldman, S. A. (2013). Genetics and genomics for the prevention and treatment of cardiovascular disease: Update. Circulation, 128(25), 2813–2851. https://doi.org/10.1161/01.cir.0000437913.98912.1d
  • Gannong, W. F. (2005). Review of medical physiology (22nd ed.). Lange Medical Books/McGraw-Hill Medical Publishing Division.
  • Goldberg, A., Curtis, C. L., & Kleim, J. A. (2015). Linking genes to neurological clinical practice: The genomic basis for neurorehabilitation. Journal of Neurologic Physical Therapy, 39(1), 52–61. doi: 10.1097/NPT.0000000000000066
  • Gorbach, T., Pudas, S., Bartrés-Faz, D., Brandmaier, A. M., Düzel, S., Henson, R. N., Idland, A.-V., Lindenberger, U., Macià Bros, D., Mowinckel, A. M., Solé-Padullés, C., Sørensen, Ø., Walhovd, K. B., Watne, L. O., Westerhausen, R., Fjell, A. M., & Nyberg, L. (2020). Longitudinal association between hippocampus atrophy and episodic-memory decline in non-demented APOE ε4 carriers. Alzheimer’s & Dementia, 12(1), e12110. https://doi.org/10.1002/dad2.12110
  • Greenwood, P. M., & Parasuraman, R. (2003). Normal genetic variation, cognition, and aging. Behavioral and Cognitive Neuroscience Reviews, 2(4), 278–306. https://doi.org/10.1177/1534582303260641
  • Gromadzka, G., Barańska-Gieruszczak, M., Ciesielska, A., Sarzyńska-Dlugosz, I., & Członkowska, A. (2005). APOE genotype and serum cholesterol in predicting risk for early death from ischemic stroke in men and women. Cerebrovascular Diseases, 20(5), 291–298. https://doi.org/10.1159/000087927
  • Gromadzka, G., Sarzynska-Dlugosz, I., & Czlonkowska, A. (2007). IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke. Journal of Neurology, Neurosurgery, and Psychiatry, 78(2), 183–186. https://doi.org/10.1136/jnnp.2006.093104
  • Guerra, J., & Cacabelos, R. (2019). Genomics of speech and language disorders. Journal of Translational Genetics and Genomics 3, 1–31. https://doi.org/10.20517/jtgg.2018.03
  • Harnish, S. M., Rodriguez, A. D., Blackett, D. S., Gregory, C., Seeds, L., Boatright, J. H., & Crosson, B. (2018). Aerobic exercise as an adjuvant to aphasia therapy: Theory, preliminary findings, and future directions. Clinical Therapeutics, 40(1), 35–48. https://doi.org/10.1016/j.clinthera.2017.12.002
  • He, Q. S., Yang, L. F., Wang, W. B., Yuan, B., Zhang, L. Y., & Guo, X. J. (2015). Vascular endothelial growth factor gene is associated with hypertensive cerebellar hemorrhage and rehabilitative treatment. Genetics and Molecular Research, 14(3), 9849–9857. https://doi.org/10.4238/2015.August.19.18
  • Hillis, A. E., Beh, Y. Y., Sebastian, R., Breining, B., Tippett, D. C., Wright, A., Saxena, S., Rorden, C., Bonilha, L., Basilakos, A., Yourganov, G., & Fridriksson, J. (2018). Predicting recovery in acute poststroke aphasia. Annals of Neurology, 83(3), 612–622. https://doi.org/10.1002/ana.25184
  • Houston, J. P., Lau, K., Aris, V., Liu, W., Fijal, B. A., Heinloth, A. N., & Perlis, R. H. (2012). Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: A candidate gene analysis. The Journal of Clinical Psychiatry, 73(6), 878–885. https://doi.org/10.4088/JCP.10m06744
  • Jak, A. J., Houston, W. S., Nagel, B. J., Corey-Bloom, J., & Bondi, M. W. (2007). Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dementia and Geriatric Cognitive Disorders, 23(6), 382–389. doi:10.1159/000101340
  • James, K. N., Clark, M. M., Camp, B., Kint, C., Schols, P., Batalov, S., Briggs, B., Veeraraghavan, N., Chowdhury, S., & Kingsmore, S. F. (2020). Partially automated whole-genome sequencing reanalysis of previously undiagnosed pediatric patients can efficiently yield new diagnoses. npj Genom. Med, 5(33), 1–8. https://doi.org/10.1038/s41525-020-00140-1
  • Kaplan, E., Goodglass, H., & Weintraub, S. (2001). Boston naming test. Pro-ed.
  • Kim, B.-R., Kim, H. Y., Chun, Y. I., Yun, Y.-M., Kim, H., Choi, D.-H., & Lee, J. (2016). Association between genetic variation in the dopamine system and motor recovery after stroke. Restorative Neurology and Neuroscience, 34(6), 925–934. https://doi.org/10.3233/RNN-160667
  • Kleim, J. A., Chan, S., Pringle, E., Schallert, K., Procaccio, V., Jimenez, R., & Cramer, S. C. (2006). BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nature Neuroscience, 9(6), 735–737. https://doi.org/10.1038/nn1699
  • Kohen, R., Cain, K. C., Mitchell, P. H., Becker, K. J., Buzaitis, A., Millard, S. P., Navaja, G. P., Teri, L., Tirschwell, D., & Veith, R. (2008). Association of serotonin transporter gene polymorphisms with post-stroke depression. Archives of General Psychiatry, 65(11), 1296–1302. https://doi.org/10.1001/archpsyc.65.11.1296
  • Kristinsson, S., Yourganov, G., Xiao, F., Bonilha, L., Stark, B. C., Rorden, C., Basilakos, A., & Fridriksson, J. (2019). Brain-derived neurotrophic factor genotype–specific differences in cortical activation in chronic aphasia. Journal of Speech, Language, and Hearing Research, 62(11), 3923–3936. https://doi.org/10.1044/2019_JSLHR-L-RSNP-19-0021
  • Kullo, I., Jarvik, G., Manolio, T., Williams, M. S., & Roden, D. M. (2013). Leveraging the electronic health record to implement genomic medicine. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 15(4), 270–271. https://doi.org/10.1038/gim.2012.131
  • Li, N., & Bartlett, C. W. (2012). Defining the genetic architecture of human developmental language impairment. Life Sciences, 90(13), 469–475. https://doi.org/10.1016/j.lfs.2012.01.016
  • Lind, J., Larsson, A., Persson, J., Ingvar, M., Nilsson, L. G., Bäckman, L., Adolfsson, R., Cruts, M., Sleegers, K., Van Broeckhoven, C., & Nyberg, L. (2006). Reduced hippocampal volume in non-demented carriers of the apolipoprotein E ɛ4: Relation to chronological age and recognition memory. Neuroscience Letters, 396(1), 23–27. doi: 10.1016/J.NEULET.2005.11.070
  • Maguire, E. A., & Frith, C. D. (2004). The brain network associated with acquiring semantic knowledge. NeuroImage, 22(1), 171–178. https://doi.org/10.1016/j.neuroimage.2003.12.036
  • Mahley, R. W., & Rall, S. C. (2000). Apolipoprotein E: Far more than a lipid transport protein. Annual Review of Genomics and Human Genetics, 1, 507–537. https://doi.org/10.1146/ANNUREV.GENOM.1.1.507
  • Marangolo, P., Fiori, V., Gelfo, F., Shofany, J., Razzano, C., Caltagirone, C., & Angelucci, F. (2014). Bihemispheric tDCS enhances language recovery but does not alter BDNF levels in chronic aphasic patients. Restorative Neurology and Neuroscience, 32(2), 367–379. https://doi.org/10.3233/RNN-130323
  • Marousi, S., Antonacopoulou, A., Kalofonos, H., Papathanasopoulos, P., Karakantza, M., & Ellul, J. (2011). Functional inflammatory genotypes in ischemic stroke: Could we use them to predict age of onset and long-term outcome? Stroke Research and Treatment, 2011, 1–7. https://doi.org/10.4061/2011/792923
  • Marshall, D. A., MacDonald, K. V., Robinson, J. O., Barcellos, L. F., Gianfrancesco, M., Helm, M., McGuire, A., Green, R. C., Douglas, M. P., Goldman, M. A., & Phillips, K. A. (2017). The price of whole-genome sequencing may be decreasing, but who will be sequenced? Personalized Medicine, 14(3), 203–211. h  ttps://d  oi.org/d  oi:1  0.2217/pme-2016-0075
  • Math, N., Han, T. S., Lubomirova, I., Hill, R., Bentley, P., & Sharma, P. (2019). Influences of genetic variants on stroke recovery: A meta-analysis of the 31,895 cases. Neurological Sciences, 40(12), 2437–2445. https://doi.org/10.1007/s10072-019-04024-w
  • McCarthy, S., Das, S., Kretzschmar, W., Delaneau, O., Wood, A. R., Teumer, A., Kang, H. M., Fuchsberger, C., Danecek, P., Sharp, K., Luo, Y., Sidore, C., Kwong, A., Timpson, N., Koskinen, S., Vrieze, S., Scott, L. J., Zhang, H., Mahajan, A., and Marchini, J. (2016). A reference panel of 64,976 haplotypes for genotype imputation. Nature Genetics, 48(10), 1279–1283. https://doi.org/10.1038/NG.3643
  • McHughen, S. A., Rodriguez, P. F., Kleim, J. A., Kleim, E. D., Crespo, L. M., Procaccio, V., & Cramer, S. C. (2010). BDNF Val66Met polymorphism influences motor system function in the human brain. Cerebral Cortex, 20(5), 1254–1262. https://doi.org/10.1093/cercor/bhp189
  • Meinzer, M., Mohammadi, S., Kugel, H., Schiffbauer, H., Flöel, A., Albers, J., Kramer, K., Menke, R., Baumgärtner, A., Knecht, S., Breitenstein, C., & Deppe, M. (2010). Integrity of the hippocampus and surrounding white matter is correlated with language training success in aphasia. NeuroImage, 53(1), 283–290. https://doi.org/10.1016/j.neuroimage.2010.06.004
  • Messing, R. O. (2003). Nervous system disorders. In Pathophysiology of disease: An introduction to clinical medicine (4th ed., pp. 143–188). Lange Medical Books/McGraw-Hill Medical Publishing Division.
  • Moon, H. I., Lee, H. J., & Yoon, S. Y. (2017). Lesion location associated with balance recovery and gait velocity change after rehabilitation in stroke patients. Neuroradiology, 59(6), 609–618. https://doi.org/10.1007/s00234-017-1840-0
  • Mozzi, A., Forni, D., Clerici, M., Pozzoli, U., Mascheretti, S., Guerini, F. R., Riva, S., Bresolin, N., Cagliani, R., & Sironi, M. (2016). The evolutionary history of genes involved in spoken and written language: Beyond FOXP2. Scientific Reports, 6(1), 6. https://doi.org/10.1038/srep22157
  • O’Donnell, C. J., Nabel, E. G., Feero, W. G., & Guttmacher, A. E. (2011). Genomics of cardiovascular disease. New England Journal of Medicine, 365, 2098–2109. https://doi.org/10.1056/NEJMra1105239
  • Opitz, B., & Friederici, A. D. (2003). Interactions of the hippocampal system and the prefrontal cortex in learning language-like rules. NeuroImage, 19(4), 1730–1737. https://doi.org/10.1016/S1053-8119(03)00170-8
  • Pearson‐Fuhrhop, K. M., & Cramer, S. C. (2010). Genetic influences on neural plasticity. Pm&r, 2(12S), S227–S240. https://doi.org/10.1016/j.pmrj.2010.09.011
  • Plassman, B. L., Welsh-Bohmer, K. A., Bigler, E. D., Johnson, M. A., Anderson, C. V., Helms, M. J., Saunders, A. M., & Breitner, J. C. S. (1997). Apolipoprotein E ϵ4 allele and hippocampal volume in twins with normal cognition. Neurology, 48(4), 985–988. https://doi.org/10.1212/WNL.48.4.985
  • Qin, L., Jing, D., Parauda, S., Carmel, J., Ratan, R. R., Lee, F. S., & Cho, S. (2014). An adaptive role for BDNF Val66Met polymorphism in motor recovery in chronic stroke. Journal of Neuroscience, 34(7), 2493–2502. https://doi.org/10.1523/JNEUROSCI.4140-13.2014
  • Qin, L., Kim, E., Ratan, R., Lee, F. S., & Cho, S. (2011). Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression. Journal of Neuroscience, 31(2), 775–783. https://doi.org/10.1523/JNEUROSCI.4547-10.2011
  • Qiu, L.-N., Sun, Y., Wang, L., Han, R.-F., Xia, X.-S., Liu, J., & Li, X. (2015). Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel. European Journal of Pharmacology, 747, 29–35. https://doi.org/10.1016/j.ejphar.2014.11.037
  • Qiu, A., Taylor, W. D., Zhao, Z., MacFall, J. R., Miller, M. I., Key, C. R., Payne, M. E., Steffens, D. C., & Krishnan, K. R. R. (2009). APOE related hippocampal shape alteration in geriatric depression. NeuroImage, 44(3), 620–626. https://doi.org/10.1016/J.NEUROIMAGE.2008.10.010
  • Rocio, G.-C., Israel, F.-C., Iniesta Juan, A., Joan, M.-F., Victor, O., José, A.-S., Vicente, V., Javier, C., & Joan, M. (2006). Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients. Stroke, 37(9), 2288–2293. https://doi.org/10.1161/01.STR.0000236636.39235.4f
  • Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. S., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-maclachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D., & Roses, A. D. (1993). Association of apolipoprotein E allele ϵ4 with late-onset familial and sporadic Alzheimer’s disease. Neurology, 43(8), 1467. https://doi.org/10.1212/WNL.43.8.1467
  • Saxena, S., & Hillis, A. E. (2017). An update on medications and noninvasive brain stimulation to augment language rehabilitation in post-stroke aphasia. Expert Review of Neurotherapeutics, 17(11), 1091–1107. https://doi.org/10.1080/14737175.2017.1373020
  • Shiner, C. T., Pierce, K. D., Thompson-Butel, A. G., Trinh, T., Schofield, P. R., & McNulty, P. A. (2016). BDNF genotype interacts with motor function to influence rehabilitation responsiveness poststroke. Frontiers in Neurology, 7, 1–10. https://doi.org/10.3389/fneur.2016.00069
  • Simmons, T. R., Flax, J. F., Azaro, M. A., Hayter, J. E., Justice, L. M., Petrill, S. A., Bassett, A. S., Tallal, P., Brzustowicz, L. M., & Bartlett, C. W. (2010). Increasing genotype-phenotype model determinism: Application to bivariate reading/language traits and epistatic interactions in language-impaired families. Human Heredity, 70(4), 232–244. https://doi.org/10.1159/000320367
  • Stanne, T. M., Åberg, N. D., Nilsson, S., Jood, K., Blomstrand, C., Andreasson, U., Blennow, K., Zetterberg, H., Isgaard, J., Svensson, J., & Jern, C. (2016). Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke. Stroke, 47(7), 1943–1945. https://doi.org/10.1161/STROKEAHA.115.012383
  • Stanne, T. M., Tjärnlund-Wolf, A., Olsson, S., Jood, K., Blomstrand, C., Jern, C., & Priller, J. (2014). Genetic variation at the BDNF locus: Evidence for association with long-term outcome after ischemic stroke. PLOS ONE, 9(12), e114156. https://doi.org/10.1371/journal.pone.0114156
  • Swaminathan, R., Huang, Y., Moosavinasab, S., Buckley, R., Bartlett, C. W., & Lin, S. M. (2016). A review on genomics APIs. Computational and Structural Biotechnology Journal, 14, 8–15. https://doi.org/10.1016/j.csbj.2015.10.004
  • Terracciano, A., Piras, M. G., Lobina, M., Mulas, A., Meirelles, O., Sutin, A. R., Chan, W., Sanna, S., Uda, M., Crisponi, L., & Schlessinger, D. (2013). Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study. The World Journal of Biological Psychiatry, 14(8), 583–589. https://doi.org/10.3109/15622975.2011.616533
  • Thompson, P., Cannon, T. D., & Toga, A. W. (2002). Mapping genetic influences on human brain structure. Annals of Medicine, 34(7), 523–536. https://doi.org/10.1080/078538902321117733
  • Vaynman, S., & Gomez‐Pinilla, F. (2006). Revenge of the “Sit”: How lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity. Journal of Neuroscience Research, 84(4), 699–715. https://doi.org/10.1002/jnr.20979
  • Vaynman, S., Ying, Z., & Gómez‐Pinilla, F. (2004). Exercise induces BDNF and synapsin I to specific hippocampal subfields. Journal of Neuroscience Research, 76(3), 356–362. https://doi.org/10.1002/jnr.20077
  • Wagle, J., Farner, L., Flekkøy, K., Wyller, T. B., Sandvik, L., Eiklid, K. L., Fure, B., Stensrød, B., & Engedal, K. (2010). Cognitive impairment and the role of the ApoE ε4-allele after stroke—A 13 months follow-up study. International Journal of Geriatric Psychiatry, 25(8), 833–842. https://doi.org/10.1002/gps.2425
  • Ward, D. D., Summers, M. J., Saunders, N. L., Janssen, P., Stuart, K. E., & Vickers, J. C. (2014). APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults. Behavioural Brain Research, 271, 309–315. https://doi.org/10.1016/j.bbr.2014.06.022
  • Watila, M. M., & Balarabe, S. A. (2015). Factors predicting post-stroke aphasia recovery. Journal of the Neurological Sciences, 352(1), 12–18. https://doi.org/10.1016/j.jns.2015.03.020
  • White, F., Nicoll, J. A. R., Roses, A. D., & Horsburgh, K. (2001). Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiology of Disease, 8(4), 611–625. https://doi.org/10.1006/nbdi.2001.0401
  • Wilson Peter, W. F., Schaefer Ernst, J., Larson Martin, G., & Ordovas Jose, M. (1996). Apolipoprotein E alleles and risk of coronary disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(10), 1250–1255. https://doi.org/10.1161/01.ATV.16.10.1250
  • Yang, L., Zhang, Z., Sun, D., Xu, Z., Yuan, Y., Zhang, X., & Li, L. (2011). Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. International Journal of Geriatric Psychiatry, 26, 495–502. https://doi.org/10.1002/gps.2552
  • Yi, X., Lin, J., Wang, Y., Zhou, Q., Wang, C., Cheng, W., & Chi, L. (2016). Association of cytochrome P450 genetic variants with clopidogrel resistance and outcomes in acute ischemic stroke. Journal of Atherosclerosis and Thrombosis, 23(10), 1188–1200. https://doi.org/10.5551/jat.33290